Drug-interaction Trial in Healthy Subjects With Oral Administration of Empagliflozin (BI 10773), Rifampicin and Probenecid
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The objectives of the trial are to investigate the effect of concurrent administration of
rifampicin and probenecid on the pharmacokinetics of empagliflozin.